Clinical Trial Update: Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis

View source ↗

Summary

This document reports a safety-focused update for a terminated trial evaluating etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Ankylosing Spondylitis, Arthritis, Psoriatic | Status: TERMINATED | Results posted: 2011-07-28